Symptom burden in hematologic malignancies

Charles S. Cleeland, Loretta A. Williams

Research output: Contribution to journalComment/debatepeer-review

12 Scopus citations

Abstract

In this issue of Blood, Geyer et al1 report results from a large multinational survey in which a sizeable proportion of patients with myeloproliferative neoplasms experienced severe symptom burden. However, standard measures of disease severity and risk did not always predict which patients would have high levels of symptom distress.

Original languageEnglish (US)
Pages (from-to)3686-3687
Number of pages2
JournalBlood
Volume123
Issue number24
DOIs
StatePublished - Jun 12 2014

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Symptom burden in hematologic malignancies'. Together they form a unique fingerprint.

Cite this